Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
VNRX
$0.24
+4.70%
VNRX
· Volitionrx Ltd
$0.24
+0.01 (+4.70%)
At close · Oct 6
View the 10-K filed Mar 31, 2026
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company concluded that these plans do not alleviate the substantial doubt about the Company's ability to continue as a going concern within one year from the date the condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Customer concentration
— top 2 customers 38% of receivables
2 customers — 38% of receivables (At December 31, 2025)
“At December 31, 2025 the two largest customer balances represented over 38% of the total outstanding accounts receivable balance.”
Market Cap
$3.54M
Shares
13.65M
Volume · Oct 6
644.26K
Avg daily vol (3M)
8.32M
All webcasts
Earnings call · FY2024 Q4
Volitionrx Ltd (VNRX) Q4 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$191,657
-21.4% YoY
Net income · derived Q4
-$5.79M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 31, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 31, 2025 · complete as-filed document